Spots Global Cancer Trial Database for Multiple Myeloma Minimal Residual Disease
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Multiple Myeloma Minimal Residual Disease
Official Title: Comparison of Three Methods to Evaluate Residual Disease in Multiple Myeloma
Study ID: NCT02627261
Conditions
Study Description
Brief Summary: Three methods including flow cytometry, next generation sequencing and determination of circulating tumor cells will be performed at different time points in patients with previously undiagnosed multiple myeloma in order to determine the most sensitive method to detect residual disease
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Hôpital Huriez, Lille, , France
Centre Hospitalier Universitaire Hôtel-Dieu de Nantes, Nantes, , France
Centre Hospitalier Lyon Sud, Pierre Bénité, , France
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
